BridgeMD
New treatment option for Albumin
Official title Functionality of Albumin in the Context of Hemodialysis
ClinicalTrials.gov ID: NCT06561191
What this study is testing
- What it's testing
- Hemodialysis treatment enables patients with end-stage chronic kidney disease to survive. At the same time, however, this treatment also increases cardiovascular mortality, in particular due to a chronically increased level of inflammation and usually incomplete removal of uraemic toxins.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years or older at least 3 month of hemodialysis treatment (3x/week) with constant dialysis treatment regimen
You likely can't join if
- Age ≤ 18 years
- Less than three months of regular (3x/week) hemodialysis treatments or less than 3 treatments/week
- Acute or chronic liver disease (Child stage A or higher or fulfillment of the of the Kings College criteria)
- Infusion of commercial human albumin (e.g. in the context of ascites drainage) in the last three months prior to study inclusion
- Acute or severe chronic infections
- Acute tumor disease
The study team makes the final eligibility decision.
Where it's taking place
- Essen, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Essen, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.